Phase II trial to assess the biochemical efficacy of transgenic alpha1-anti-trypsin as an effective treatment of cystic fibrosis

L. Martin*, D. Downey, J. S. Elborn, D. Bilton, M. T. Keogan, J. Edgar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Phase II trial to assess the biochemical efficacy of transgenic alpha1-anti-trypsin as an effective treatment of cystic fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences